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Predictors of mortality of postoperative enteric fistula in GI cancers 419Enteric fistula;
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Mortalitycenter. We included patients who developed enteric fistulas after surgery for gastrointestinal
(GI) cancer between January 2005 and December 2010. Patient demographics and data on
preoperative and pre-parenteral nutritional statuses were compared between surviving and
deceased patients. Logistic regression analysis and receiver operating characteristic (ROC)
curves were used to determine the predictors and cut-off values, respectively. Patients with
incomplete data and preoperative heart, lung, kidney, and liver diseases were excluded from
the study; thus, out of 65 patients, 43 were enrolled. Logistic regression analysis showed that
blood urea nitrogen-to-creatinine (BUN/Cr) ratio [p Z 0.007; OR Z 0.443, 95% confidence
interval (CI), 0.245e0.802] was an independent predictor of mortality in patients who devel-
oped enteric fistulas after surgery for GI cancer. In conclusion, the results of our study showed
that a high preoperative BUN/Cr ratio increases the risk of mortality in patients who develop
enteric fistulas after surgery for GI cancer.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Development of an enteric fistula after surgery is a major
therapeutic complication [1]. Althoughmost patients receive
conservative treatment, such treatmentsmay sometimes fail
and reoperation may be necessary, resulting in poor prog-
nosis. With improved nutritional support, infection control,
and adequate surgical intervention [2], mortality rates have
decreased from 40e65% to 5.3e21.3% in the past few
decades [3e9]. Gastrointestinal (GI) cancer generally
develops in the elderly; these patients show malnutrition or
a combination of medical problems before surgery, which
complicates postoperative care and increases the morbidity
and mortality rates of these patients. Some of these patients
may have received chemotherapy and radiotherapy before
surgery, which may worsen the prognosis if complications
such as enteric fistulas develop. Although nutritional support
and antibiotic treatments have improved outcomes in most
of the cases with postoperative complications [10,11], the
effectiveness of these approaches in GI cancer patients with
postoperative enteric fistulas is largely unknown. Most GI
cancer patients can survive after surgery even if enteric
fistulas develop. The objective of this study was to identify
the risk factors for mortality in GI cancer patients with
postoperative enteric fistulas.Patients and methods
Patients
We collected data from patients who developed enteric
fistulas after surgery for GI cancer between January 2005
and December 2010. The study was conducted in a tertiary
medical center with 1200 beds in central Kaohsiung. The
study protocol was approved by the institutional review
board of Kaohsiung Medical University. Patients who had
primary cancers such as esophageal, gastric, and colorectal
cancers were eligible for surgery. However, those with
a medical history of chronic heart failure (CHF), liver
cirrhosis, severe chronic obstructive pulmonary disease,
and end-stage renal disease requiring regular hemodialysis
were excluded. Patients who had undergone radiotherapy
and chemotherapy before surgery were also excluded. We
also excluded patients with conflicting, ambiguous, ormissing data. Parenteral nutrition therapy was adminis-
tered for achieving the daily caloric requirement if any of
the included patients developed enteric fistulas. A support
team was in charge of evaluating and monitoring the
nutritional therapy, the patient’s physical status, and
comprehensive data collection. The daily energy require-
ment of each patient was calculated using the Har-
riseBenedict equation and adjusted by multiplying with
activity and stress factors. The protein supplementation
was approximately 1.5e2.0 g/kg/day. The support team
evaluated all the nutritional requirements in these
patients. All physicians and staff members were blinded to
the study design and methods.
During the course of treatment, similar eligibility
criteria were used to administer parenteral nutrition
therapy. The diagnosis of enteric fistula was confirmed
when the drainage amount increased with respect to
intestinal contents; consequently, parenteral nutrition
therapy was given along with antibiotics according to the
patient’s clinical status. Patients were divided into two
groups: those who survived with spontaneous closure of
enteric fistulas and those who expired due to sepsis caused
by complications during treatment.
Patient demographics and preoperative medical history
included gender, age, diagnosis of primary GI-tract cancer,
Union of International Cancer Control (UICC) stage of the
cancer, presence of medical conditions, mortality, duration,
and complications with parenteral nutritional supplement
were recorded by a senior member of the support team. The
data collected by the support group was rechecked by
a senior physician. The patients’ laboratory test data were
obtained as per routine procedures performed before surgery
[determination of white blood cell (WBC) count, and tests for
glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic
transaminase (GPT), blood urea nitrogen (BUN), and creati-
nine (Cr)]; further, standardized total parenteral nutrition
(TPN) was started at our hospital. Total protein (TP),
albumin, and globulin were measured before starting TPN.
CockrofteGault formula was used to estimate the patients’
glomerular filtration rates (GFRs).Statistical analysis
Normally distributed data were presented as mean 
standard deviation values. Categorical variables were
420 H.-L. Lin et al.analyzed using c2 and ManneWhitney U tests. Logistic
regression analysis was performed to determine the predic-
tors of mortality in patients with complications caused by
enteric fistula. In the logistic forward regression model,
we represented the magnitude of association between the
dependent variable and each independent variable by
obtaining odds ratios (OR) and 95% confidence intervals (CI).
Model fit was determined using standard likelihood ratio
tests. Data analyses were performed using SPSS software
(Version 15; SPSS Inc., Chicago, IL, USA). Two-tailed p values
less than 0.05 were considered statistically significant. The
diagnostic values of different variables and the best cut-off
values were determined using receiver-operating charac-
teristic (ROC) curves. The cut-off value for each variable
was set at the points representing the highest accuracy of
analysis (minimal false negative and false positive results).
Results
During the study period, 65 patients were diagnosed with
enteric fistula after surgery for GI cancer. Three patients
receiving neoadjuvant chemotherapy, two receiving
preoperative radiotherapy, four with medical history of
liver cirrhosis, three with undetermined pathology reports,
and 10 with incomplete data were excluded. Thus, 43
patients were enrolled in the study.
Demographic data of these 43 GI-tract cancer patients
are presented in Table 1. Sixteen patients died (eight
men and eight women; mean age, 61.81  17.44 years), and
27 survived (20 men and seven women; mean age,
62.67  10.60 years). There was no significant intergroup
difference in the types of GI cancers (p Z 0.523). No
intergroup differences were noted in the number of cases of
diabetes mellitus (p Z 0.614). In the preoperative labora-
tory data, only BUN values were significantly differentTable 1 Clinical characteristics of the primary gastrointestinal
Survival group (n Z 2
Age (y), mean  SD 62.67  10.60
Sex, no. of women (%) 7 (25.9%)
Primary GI cancer
Esophageal cancer 1
Gastric cancer 8
Colorectal cancer 18
Diabetes (Y/N) 22/5
Laboratory data (normal range)
BUN (7e20 mg/dL) 12.73  4.67
Cr (0.8e1.4 mg/dL) 0.91  0.22
GOT (1e21 units/L) 32.96  16.35
GPT (7e27 units/L) 32.81  30.16
Total protein (g/dl) 6.00  0.53
Globulin (g/dl) 2.82  0.44
Albumin (g/dl) 3.18  0.52
WBC (4.3e10.8  103/mm3) 12162.71  6540.23
Glomerular filtration rate 70.28  23.39
BUN/Cr (10:1e20:1) 14.00  4.82
BUN Z blood urea nitrogen; Cr Z creatinine; GOT Z glutamic-oxalobetween the two groups (pZ 0.001). Preoperative GFR did
not significantly differ between the two groups (pZ 0.182).
All variables in the univariate analyses were analyzed in
a logistic forward regression model. The BUN/Cr value
(p Z 0.007; OR Z 0.443, 95% CI, 0.245e0.802) was iden-
tified as an independent predictor of mortality. The model
adequately fitted the data with the HosmereLemeshow
statistics (pZ 0.926), while 74.5% of the variation could be
explained by the Nagelkerke R square model (Table 2). A
cut-off BUN/Cr value of 17 would have permitted the
sensitivity and specificity to be 84.2% and 79.4%, respec-
tively (area under ROC curve, 0.848) (Fig. 1).
Discussion
Preoperative laboratory analyses in primary GI cancer
patients requiring surgery, would be useful to predict the
mortality caused by postoperative enteric fistulas. In this
study, we found that patients with a higher BUN/Cr value
had a higher average mortality rate (37.21%); hence,
preoperative BUN/Cr ratio could be used to predict post-
operative mortality in cases showing enteric fistulas.
To reduce the bias that may have influenced the results
of surgery, we focused on patients with only primary GI
cancers; to this end, patients with preoperative medical
conditions, including liver cirrhosis, uremia, and CHF, were
excluded. The uniformity in the pre-operative status of the
patients reflected in their preoperative laboratory data,
which showed similar serum TP, albumin, and globulin
levels. In addition, the other preoperative data (WBC, GOT,
GPT, and Cr) showed no intergroup differences. Further-
more, although preoperative serum BUN level was different
between the two groups, preoperative GFR levels showed
no significant difference. This meant that the renal func-
tion of patients in the two groups did not statistically differ.(GI) cancer with postoperative enteric fistula.
7) Mortality group (n Z 16) p
61.81  17.44 0.861
8 (50%) 0.109
2 0.523
5
9
12/4 0.614
22.16  9.16 0.001
0.95  0.30 0.600
27.92  16.32 0.367
32.96  16.35 0.249
6.12  0.86 0.630
3.02  0.62 0.245
3.11  0.48 0.652
9266.45  4063.89 0.071
62.39  23.92 0.182
22.00  6.57 <0.001
acetic transaminase; GPT Z glutamic-pyruvic transaminase.
Table 2 Independent risk factors associated with
mortality of enteric fistula.*
OR 95% CI p
BUN/Cr 0.443 0.245e0.802 0.007
Age 0.889 0.780e1.013 0.077
*The risk factors included in the logistic regression model were
gender, glomerular filtration rate (GFR), blood urea nitrogen
(BUN), creatinine (Cr), diseases, Diabetic mellitus (DM),
glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic
transaminase (GPT), Total protein (TP), albumin, and globulin.
The p value of BUN/Cr was <0.05.
Predictors of mortality of postoperative enteric fistula in GI cancers 421Although there have been recent advances in nutritional
therapy, infection control, and surgical techniques, enteric
fistulas are a major cause of morbidity and mortality [1].
Correction of intravascular volume deficit, drainage of
abscesses, and control of fistula effluent are the primary
procedures in enteric fistula management [12]. Serum
albumin level less than 3.0 g/dL, high-output fistulas with
hydroelectrolytic deficit at diagnosis, multiple fistulas,
jejunal site, sepsis, and complex fistulous tracts were asso-
ciated with patient mortality [13,14]. Therefore, manage-
ment of the intravascular volume is important for patient
management. The cut-off value of 17 estimated by using the
ROC curve may provide the strategy for fluid supply.
An increased BUN/Cr value along with decrease in the
effective circulating blood volume is found in patients with
renal disease, congestive heart failure, gastrointestinal
bleeding, and acute urinary tract obstruction [15e17]. High
BUN/Cr values also indicate an increased risk of hospitali-
zation and all-cause mortality in patients with CHF [18,19].Figure 1. Receiver-operating characteristic (ROC) curves of
the blood urea nitrogen-to-creatinine (BUN/Cr) ratio in the
prediction of mortality rate of 43 gastrointestinal (GI)-tract
cancer patients with postoperative enteric fistulas. One of the
ROC plots with a cut-off value of 17 for BUN/Cr ratio was
selected for mortality prediction. The plot is highlighted;
figures in parentheses indicate sensitivity and specificity. The
area under the ROC curve is 0.848 [95% confidence interval
(CI), 0.726e0.969].We found higher mortality rates in patients with higher
ratios in the group with post-surgical enteric fistulas.
Because we excluded patients with heart failure, renal
disease, urinary tract obstruction, and preoperative GI
bleeding, the increased BUN/Cr ratio could be attributed to
preoperative dehydration. Postoperative management of
enteric fistula is important for patient survival. Therefore,
more standardized procedures are applied to manage
such complications. The postoperative management of our
patients was consistent, which reduced bias caused by
different postoperative management options. The signifi-
cant intergroup difference in preoperative BUN/Cr values
merely represented the difference in BUN values. Patients
with high-output fistulas have higher mortality rates [14].
Renal function may be an important factor influencing the
clinical outcome in cases of fistula development. However,
preoperative dehydration might result in renal dysfunction
that could eventually deteriorate the patient’s condition
resulting in higher mortality rates. Therefore, prevention of
dehydration is important in the preoperative preparatory
phase.
Our study had the following limitations. We could not
determine if the patients were on a high-protein diet
before the operation or showed muscle wasting. However,
serum TP, albumin, and globulin levels did not show any
difference between the two groups, which might indicate
that the preoperative nutritional status did not affect the
clinical outcome. Although the BUN/Cr ratio may reveal the
effective preoperative circulating blood volume, a high
ratio may be a surrogate marker of other differences.
Furthermore, there was no difference between the two
groups in renal function tests (except the serum BUN level);
however, we think prevention of iatrogenic injury to the
kidneys and assessment of renal function are important
factors influencing the mortality rates after enteric fistula
development. Some important factors were not analyzed
owing to the retrospective nature of the study. Previous
studies have corroborated our finding of high-output fistulas
being a risk factor for patient mortality [14]. Therefore, we
did not focus on such fistulas. Surgery may be an important
factor influencing patient outcome because it is detri-
mental to patients who lack spontaneous healing, and may
introduce a bias in the postoperative procedures. Nutri-
tional status and supply during follow-up could be factors
affecting mortality; however, we followed a standard
procedure for our postoperative patients.
In this study, we identified the BUN/Cr ratio as an inde-
pendent risk factor to predict patient survival after post-
operative enteric fistula development. We recommend
prevention of dehydration prior to surgery in these patients.
Additional clinical information is essential to confirm the
hypothesis that dehydration may be related to mortality
rates. Therefore, further studies are required to investigate
if preoperative fluid administration could improve the clin-
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